An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy.
(2023) Blood Advances — Vol. 7, n° 18, p. 5480-5484 (2023)
Files
2023_Farooq_Blood_Adv.pdf
Open Access - Adobe PDF
- 272.15 KB
Details
- Authors
Brandt, Justin S 
Cardonick, Elyce Polushkina, Evgeniya Evens, Andrew M
- Abstract
- Cancer complicates ~1 in 1000 pregnancies, which translates into ~4000 cases annually in the United States. Lymphoma is the fourth most common malignancy and the most common hematological malignancy present during pregnancy. Although there are published reports of lymphoma occurring during pregnancy, most are among patients with newly diagnosed disease, and there is a near absence of data regarding the presentation, management, and maternal and neonatal outcomes of patients with relapsed/refractory lymphoma that occurs during pregnancy. [...]
- Affiliations
Citations
Farooq, F., Brandt, J. S., Cardonick, E., Polushkina, E., Vose, J., Ahmed, S., Ramakrishnan Geethakumari, P., Olszewski, A. J., Yasin, H., Farooq, U., Hamad, N., Lin, Y., Maggen, C., Fruscio, R., Mhallem Gziri, M., Steffensen, K. D., Amant, F., & Evens, A. M. (2023). An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy. Blood Advances, 7(18), 5480-5484. https://doi.org/10.1182/bloodadvances.2023010090 (Original work published 2023)